Listar por autor "Urueña, Analía"
Mostrando ítems 1-5 de 5
-
Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina
Urueña, Analía; Micone, Paula; Magneres, María Cecilia; McGovern, Ian; Mould-Quevedo, Joaquín; Rocha Sarmento, Túlio Tadeu; Giglio, Norberto (2022)Background: Quadrivalent cell-based influenza vaccines (QIVc) avoid egg-adaptive mutations and can be more effective than traditional quadrivalent egg-based influenza vaccines (QIVe). This analysis compared the cost-effectiveness ... -
Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
Urueña, Analía; Micone, Paula; Magneres, María Cecilia; Mould-Quevedo, Joaquín; Giglio, Norberto (2022)The burden of seasonal influenza disease in Argentina is considerable. The cost-effectiveness of trivalent (TIV) versus quadrivalent influenza vaccine (QIV) in Argentina was assessed. An age-stratified, static, decision-tree ... -
Epidemiology of Dengue in Argentina during the 2010/11 to 2019/20 Seasons: A Contribution to the Burden of Disease
Rapaport, Solana; Mauriño, Mariana; Morales, María Alejandra; Fabbri, Cintia; Luppo, Victoria; Buyayisqui, María Pía; Varela, Teresa; Giovacchini, Carlos; Urueña, Analía (2024)Background: Dengue is an important public health problem in Argentina, as in many other countries. We reviewed and updated information on the dengue disease burden in Argentina over a 10-year period. Methods: We conducted ... -
Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries
Urueña, Analía; Machado, Ricardo; Cunha, Juarez; López Colmano, Clara; Rancaño, Carolina; Kfouri, Renato; Pirez, Catalina; Bonhevi, Pablo; Calvo, Mario; Rodríguez, Mónica; Torres, Jaime; Chan, Florencia; Ballalai, Isabella (2023)This article presents attitudes and practices regarding COVID-19 vaccination in the South American population. The study collected data from a self-administered survey distributed through social media platforms between ... -
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion
Postma, Maarten; Fisman, David; Giglio, Roberto; Márquez-Peláez, Sergio; Nguyen, Van Hung; Pugliese, Andrea; Ruíz-Aragón, Jesús; Urueña, Analía; Mould-Quevedo, Joaquín (2023)Influenza vaccination can benefit most populations, including adults ≥ 65 years of age, who are at greater risk of influenza-related complications. In many countries, enhanced vaccines, such as adjuvanted, high-dose, and ...